With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (NASDAQ: VKTX) are a hot commodity, to ...

In a report released today, Justin Zelin from BTIG maintained a Buy rating on Janux Therapeutics Inc (JANX – Research Report), with a ...

Analyst Michael Ulz of Morgan Stanley maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report), retaining the price target ...

Lexaria Bioscience Corp. (the "Company" or "Lexaria"), a global innovator in drug delivery platforms provides the following glucagon-like peptide-1 ("GLP-1") industry update.

Viking Therapeutics (VKTX) is up more than +5% after the company’s experimental pill, VK2735, showed weight loss in patients at higher doses with limited side effects. Air Transport Services Group ...

According to KPMG Private Enterprise's Venture Pulse report, despite continued uncertainty in the market, AI continued to see incredibly strong VC investment in the US during Q3'24, led by a $1.5 ...

Neighbours airs a terrifying workplace accident for Cara Varga-Murphy next week. Cara is rushed to hospital after a mishap involving Holly Hoyland at the Lassiters complex. The worrying scenes play ...